Induction of Clinical Response Using Rifaximin in Crohn's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
Antibiotics have been used to treat Crohn\'s disease symptoms with the best studied antibiotics being Cipro and Flagyl. Rifaximin is a poorly absorbed oral antibiotic that is FDA approved for travelers\' diarrhea. It works by inhibiting bacterial reproduction. It is very poorly absorbed and over 97% of the drug taken orally is excreted in the feces. The purpose of this study is to evaluate the potential benefits and safety of Rifaximin for the treatment of moderate to severe symptoms of Crohn\'s Disease.
Epistemonikos ID: 9add20caa22c2bbd7d97b3f446e069f5b898b99b
First added on: May 04, 2024